Medical device marketing that works

A report examining the marketing communications channels available to device manufacturers today, by TforG for Encompass Content Solutions, was compiled from results of numerous interviews with device industry leaders, including senior managers in sales, marketing, operations and health care providers – from medical practitioners to hospital staff and hospital administrators.

Photo: Medical device marketing that works

Findings show that in both mature markets (Shift Markets) and emerging markets (Growth Markets), traditional channels – specifically, face-to-face contact by industry representatives, including those on congresses and exhibitions – still represent the most important way to reach customers.

‘However,’ TforG comments, ‘in mature markets particularly, the relevant target audience is broadening to an increasingly diverse group of decision makers, requiring device companies to consider the impact this shift has on content needs, sources and channels.

‘As a result, third parties – such as evidence-generating organisations and HCTA institutes – have significantly impacted the decision-making process, while social media maintains a limited application, except in specific situations such as large (patient) communities.

* For a free report download go to TforG (www.tforg.com) and Encompass Content Solutions (http://encompass.transperfect.com).

11.11.2014

More on the subject:
Read all latest stories

Related articles

Photo

Patient management solutions

Philips acquires start-up Medumo

Royal Philips announced that it has expanded its patient management solutions in the US with the acquisition of Boston-based start-up company Medumo. Founded in 2013, Medumo has developed a…

Photo

Aiming to drive health investments

Dubai’s notable healthcare

Formed in 2007 – under the directives of Sheikh Mohammed bin Rashid Al Maktoum, the Vice President, Prime Minister, and Ruler of Dubai, UAE – the Dubai Health Authority (DHA) oversees the…

Photo

Collaboration

Partnership to enhance pharma drug development and single cell research

Olympus and Cytosurge AG, developer of the disruptive and patented FluidFM technology, announced their collaboration to significantly expand the awareness and availability of the FluidFM BOT* – a…